B. Metzler seel. Sohn & Co. Holding AG Purchases Shares of 14,871 GE HealthCare Technologies Inc. (NASDAQ:GEHC)

B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 14,871 shares of the company's stock, valued at approximately $1,396,000.

A number of other hedge funds and other institutional investors have also modified their holdings of GEHC. Pathway Financial Advisers LLC purchased a new stake in shares of GE HealthCare Technologies during the first quarter worth about $25,000. LGT Financial Advisors LLC grew its stake in GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock worth $25,000 after purchasing an additional 251 shares in the last quarter. Fred Alger Management LLC acquired a new position in GE HealthCare Technologies in the second quarter worth about $26,000. Capital Performance Advisors LLP acquired a new position in GE HealthCare Technologies in the third quarter worth about $26,000. Finally, Ashton Thomas Securities LLC acquired a new position in GE HealthCare Technologies in the third quarter worth about $26,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of the business's stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the sale, the chief executive officer now owns 24,298 shares of the company's stock, valued at $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.27% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. UBS Group downgraded GE HealthCare Technologies from a "neutral" rating to a "sell" rating and decreased their price target for the stock from $84.00 to $74.00 in a research note on Thursday, September 26th. Redburn Atlantic upgraded GE HealthCare Technologies to a "strong-buy" rating in a research note on Thursday, August 1st. JPMorgan Chase & Co. assumed coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They issued a "neutral" rating and a $90.00 price target for the company. Wells Fargo & Company lifted their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a research note on Thursday, October 31st. Finally, BTIG Research upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 target price for the company in a research note on Wednesday, September 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $94.36.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC traded up $0.44 during midday trading on Friday, hitting $82.44. 5,934,944 shares of the company's stock were exchanged, compared to its average volume of 3,795,040. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The stock's 50 day moving average price is $88.35 and its 200-day moving average price is $83.60. The firm has a market cap of $37.66 billion, a P/E ratio of 22.65, a PEG ratio of 2.94 and a beta of 1.24. GE HealthCare Technologies Inc. has a twelve month low of $66.39 and a twelve month high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.06 by $0.08. The business had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business's revenue was up .9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.99 earnings per share. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.29 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a dividend of $0.03 per share. The ex-dividend date was Friday, October 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. GE HealthCare Technologies's dividend payout ratio is presently 3.30%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.